Ads
related to: topiramate for nightmares and dementia treatmentGoodRx was honored as dot.LA’s Startup of the Year for 2020. - dot.LA
Search results
Results from the WOW.Com Content Network
Topiramate, sold under the brand name Topamax among others, is a medication used to treat epilepsy and prevent migraines. [9] It has also been used in alcohol dependence and essential tremor. [9] For epilepsy this includes treatment for generalized or focal seizures. [10] It is taken orally (by mouth). [9]
Topiramate: Topamax Sodium valproate [note 1] Convulex, Depakene, Depakine Enteric, Orfiril, Stavzor Divalproex sodium [note 2] Depakote, Epival, Ergenyl Chrono Sodium valproate and valproic acid in 2.3:1 ratio: Depakine Chrono, Depakine Chronosphere, Epilim Chrono, Epilim Chronosphere
Vistaril (hydroxyzine) – an antihistamine for the treatment of itches and irritations, an antiemetic, as a weak analgesic, an opioid potentiator, and as an anxiolytic Vyvanse ( lisdexamfetamine ) – a pro-drug stimulant used to treat attention deficit hyperactivity disorder and binge eating disorder ; Vyvanse is converted into Dexedrine in vivo
This isn’t the first time that better sleep has been linked with a lower risk of dementia: A study published in October even found that people with sleep apnea are more likely to develop dementia.
Topiramate, also sold under the brand name Topamax, is a drug approved by the U.S. Food and Drug Administration (FDA) for epilepsy and migraines. It’s also prescribed off-label for weight loss.
The findings showed that middle-aged people (35 to 64) who experienced bad dreams on a weekly basis were four times more likely to suffer cognitive decline over the following decade, while older ...
The treatment depends on whether or not there is a comorbid PTSD diagnosis. [1] About 4% of American adults are affected. [1] Studies examining nightmare disorders have found that the prevalence rates ranges 2–6% with the prevalence being similar in the US, Canada, France, Iceland, Sweden, Belgium, Finland, Austria, Japan, and the Middle East ...
Cardiovascular treatments and dementia risk: The takeaways. Overall, the data adds to understanding regarding cardiovascular disease drugs and how they may affect dementia risk.